{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:33:03Z","timestamp":1793395983062,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015622","name":"Ministerul Cercet\u0103rii \u015fi Inov\u0103rii","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005186","name":"Corporation for National and Community Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["PN-III-P1-1.1-PD-2016-0233"],"award-info":[{"award-number":["PN-III-P1-1.1-PD-2016-0233"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejps.2019.104974","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T22:32:23Z","timestamp":1561501943000},"page":"104974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation"],"prefix":"10.1016","volume":"137","author":[{"given":"Ionut","family":"Dragostin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana M.","family":"Dragostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangram Keshari","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Tatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumini\u021ba","family":"Confederat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M.","family":"Ghiciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Diculencu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lina E.","family":"Lupu\u0219oru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L.","family":"Zamfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.104974_bb0005","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.ejmech.2010.04.025","article-title":"Synthesis and anti-mycobacterial evaluation of some pyrazine\u20112\u2011carboxylic acid hydrazide derivatives","volume":"45","author":"Abdel-Aziz","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2017.07.004","article-title":"Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents","volume":"138","author":"Abdelrahman","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0015","series-title":"Validation of Pharmaceutical Processes","author":"Agalloco","year":"2007"},{"key":"10.1016\/j.ejps.2019.104974_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.femsle.2005.07.022","article-title":"In vitro and ex vivo antimy-cobacterial potential of azole drugs against mycobacterium tuberculosis H37Rv","volume":"251","author":"Ahmad","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejps.2019.104974_bb0025","first-page":"24","article-title":"Histochemical uses of haematoxylin - a review Godwin Avwioro","volume":"1","author":"Avwioro","year":"2011","journal-title":"JPCS."},{"key":"10.1016\/j.ejps.2019.104974_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157340612800493647","article-title":"Small molecule hydrazide agents to inhibit growth and proliferation of mycobacterium tuberculosis","volume":"8","author":"Bartzatt","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133129","article-title":"Deletion of cyp125 confers increased sen-sitivity to azoles in mycobacterium tuberculosis","volume":"10","author":"Carroll","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2019.104974_bb0040","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/AAC.00753-13","article-title":"Efficacy and safety of metronidazole forpulmonary multidrug-resistant tuberculosis","volume":"57","author":"Carroll","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.104974_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bmcl.2007.11.091","article-title":"Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives","volume":"18","author":"Carvalho","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.104974_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejmech.2018.01.071","article-title":"New hydrazides derivatives of isoniazid against mycobacterium tuberculosis: higher potency and lower hepatocytotoxicity","volume":"146","author":"Castelo-Branco","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0055","doi-asserted-by":"crossref","unstructured":"Cheaburu Yilmaz, C. N., et al., 2017. Toxicity, biocompatibility, pH-responsiveness and methotrexate release from PVA\/hyaluronic acid cryogels for psoriasis therapy, Polymers. 123: 9, 1\u201314.","DOI":"10.3390\/polym9040123"},{"key":"10.1016\/j.ejps.2019.104974_bb0060","first-page":"1","article-title":"The influence of excipients on physical and pharmaceutical properties of oral lyophilisates containing a pregabalin-acetaminophen combination","author":"Chiriac","year":"2017","journal-title":"Expert Opin. Drug Del"},{"key":"10.1016\/j.ejps.2019.104974_bb0065","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ejmech.2007.08.003","article-title":"Synthesis and anti-mycobacterial activity of (E)-N0-(monosubstituted-benzylidene) isonicotinohydrazide derivatives","volume":"43","author":"Da Silva Louren\u00e7o","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejps.2019.104974_bb0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10601325.2017.1320754","article-title":"The importance of polymers for encapsulation process and for enhanced cellular functions","volume":"54","author":"Dragostin","year":"2017","journal-title":"J. Macromol. Sci. A"},{"key":"10.1016\/j.ejps.2019.104974_bb0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, lowtechnology MIC determination with clinical mycobacterium tuberculosis isolates by using the microplate Alamar blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejps.2019.104974_bb0080","unstructured":"Global tuberculosis report 2018. (Geneva, World Health Organization, 2018. (Licence: CC BY-NC-SA 3.0 IGO).,"},{"key":"10.1016\/j.ejps.2019.104974_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","article-title":"New agents for the treatment of drug-resistant mycobacterium tuberculosis","volume":"102","author":"Hoagland","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.104974_bb0090","first-page":"239","article-title":"Protective effects of salep against isoniazid liver toxicity in wistar rats","volume":"8","author":"Hossein","year":"2017","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.ejps.2019.104974_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.04.002","article-title":"Isoniazid derivatives and their anti-tubercular activity","volume":"133","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0100","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/AAC.01468-06","article-title":"Metronidazole plus rifampin sterilizes long-term dormant M. tuberculosis","volume":"51","author":"Iona","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.104974_bb0105","series-title":"Biological Evaluation of Medical Devices \u2013 Part 5: Tests for Cytotoxicity: In Vitro-Methods","author":"ISO 10993-5","year":"2003"},{"issue":"3","key":"10.1016\/j.ejps.2019.104974_bb0110","first-page":"336","article-title":"Determination of the activity of standard anti-tuberculosis drugs against intramacrophage mycobacterium tuberculosis, in vitro: MGIT 960 as a viable alternative for BACTEC 460","volume":"18","author":"Jhamb","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2019.104974_bb0115","series-title":"Pneumologie \u015fi terapie intensiv\u0103","author":"Loscalzo","year":"2017"},{"key":"10.1016\/j.ejps.2019.104974_bb0120","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2005.03.065","article-title":"In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes","volume":"15","author":"Maccari","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.104974_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0014-827X(00)00072-0","article-title":"Building a pharmacophore model for a novel class of antitubercular compounds","volume":"55","author":"Manetti","year":"2000","journal-title":"Il Farm"},{"key":"10.1016\/j.ejps.2019.104974_bb0130","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1016\/j.bmc.2013.06.013","article-title":"Synthesis and bioevaluation of some new isoniazid derivatives","volume":"21","author":"Matei","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0135","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1016\/j.bmc.2007.05.053","article-title":"Synthesis and antimycobacterial activity of 4\u2011(5\u2011substituted\u20111,3,4\u2011oxadiazol\u20112\u2011yl) pyridines","volume":"15","author":"Navarrete-Vazquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0140","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.02154-12","article-title":"Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions","volume":"57","author":"Piccaro","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2019.104974_bb0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10973-009-0337-4","article-title":"Thermal analysis of 2D PVA\/CNTs membrane","volume":"97","author":"Samal","year":"2009","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejps.2019.104974_bb0150","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/mabi.201300513","article-title":"Enzymatic mineralization of silk scaffolds","volume":"14","author":"Samal","year":"2014","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejps.2019.104974_bb0155","doi-asserted-by":"crossref","first-page":"53547","DOI":"10.1039\/C4RA10070K","article-title":"Silk\/chitosan biohybrid hydrogels and scaffolds via green technology","volume":"4","author":"Samal","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2019.104974_bb0160","doi-asserted-by":"crossref","first-page":"23098","DOI":"10.1021\/acsami.5b06813","article-title":"Multilayered magnetic gelatin membrane scaffolds","volume":"7","author":"Samal","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2019.104974_bb0165","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1021\/acsami.5b00529","article-title":"Biomimetic magnetic silk scaffolds","volume":"7","author":"Samal","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2019.104974_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molstruc.2005.11.023","article-title":"Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4\u2011difluoro\u2011N0\u2011isonicotinoylbenzohydrazide and 2,4\u2011dichloro\u2011N0\u2011isonicotinoylbenzohydrazide hydrochloride","volume":"788","author":"Silva","year":"2006","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2019.104974_bb0175","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmcl.2005.07.011","article-title":"Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones","volume":"15","author":"Sriram","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2019.104974_bb0180","first-page":"2","article-title":"Current overview of anti-tuberculosis drugs: metabolism and toxicities","volume":"6","author":"Susmita","year":"2016","journal-title":"Mycobact Dis"},{"key":"10.1016\/j.ejps.2019.104974_bb0185","first-page":"39","article-title":"An update on global tuberculosis (TB)","volume":"6","author":"Talip","year":"2013","journal-title":"Infectious Diseases: Research and Treatment"},{"key":"10.1016\/j.ejps.2019.104974_bb0190","doi-asserted-by":"crossref","unstructured":"Tihan, G. T. et al., 2018. Alkaline phosphatase immobilization on new chitosan membranes with Mg2+ for biomedical applications. Mar. Drugs. 287:16, 1\u201314.","DOI":"10.3390\/md16080287"},{"key":"10.1016\/j.ejps.2019.104974_bb0195","first-page":"38","article-title":"A hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"7","author":"Vidyasagar","year":"2012","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.ejps.2019.104974_bb0200","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejmech.2018.04.017","article-title":"New lipophilic isoniazid derivatives and their 1,3,4\u2011oxadiazole analogues: synthesis, antimycobacterial activity and investigation of their mechanism of action","volume":"151","author":"Vos\u00e1tka","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2019.104974_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(15)00499-5","article-title":"The transmission of mycobacterium tuberculosis in high burden settings","volume":"16","author":"Yates","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719302374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719302374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:55:43Z","timestamp":1778558143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719302374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":41,"alternative-id":["S0928098719302374"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.104974","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New isoniazid derivatives with improved pharmaco-toxicological profile: Obtaining, characterization and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.104974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104974"}}